Business Description
Procaps Group SA
NAICS : 325411
SIC : 2833
ISIN : LU2376511205
Description
Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.07 | |||||
Equity-to-Asset | 0.07 | |||||
Debt-to-Equity | 8.75 | |||||
Debt-to-EBITDA | 2.05 | |||||
Interest Coverage | 0.5 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 1.38 | |||||
Beneish M-Score | -2.85 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.1 | |||||
3-Year EBITDA Growth Rate | 30.3 | |||||
3-Year Book Growth Rate | 84.5 | |||||
Future 3-5Y Total Revenue Growth Rate | 2.42 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 52.71 | |||||
9-Day RSI | 49.42 | |||||
14-Day RSI | 47.77 | |||||
6-1 Month Momentum % | -39.34 | |||||
12-1 Month Momentum % | -57.54 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.21 | |||||
Quick Ratio | 0.79 | |||||
Cash Ratio | 0.08 | |||||
Days Inventory | 203.49 | |||||
Days Sales Outstanding | 107.14 | |||||
Days Payable | 176.65 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -5.92 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 55.92 | |||||
Operating Margin % | 9.05 | |||||
Net Margin % | 16.4 | |||||
FCF Margin % | -1.8 | |||||
ROE % | Neg. Equity | |||||
ROA % | 14.27 | |||||
ROIC % | 7.98 | |||||
ROC (Joel Greenblatt) % | 54.39 | |||||
ROCE % | 57.68 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 3.98 | |||||
Forward PE Ratio | 12.97 | |||||
PE Ratio without NRI | 5.69 | |||||
PS Ratio | 0.65 | |||||
PB Ratio | 8.89 | |||||
Price-to-Operating-Cash-Flow | 11.58 | |||||
EV-to-EBIT | 4.52 | |||||
EV-to-Forward-EBIT | 7.99 | |||||
EV-to-EBITDA | 3.99 | |||||
EV-to-Revenue | 1.38 | |||||
EV-to-Forward-Revenue | 1.27 | |||||
EV-to-FCF | -76.65 | |||||
Earnings Yield (Greenblatt) % | 22.12 | |||||
FCF Yield % | -2.5 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PROC
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Procaps Group SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 406.089 | ||
EPS (TTM) ($) | 0.652 | ||
Beta | 0 | ||
Volatility % | 29.18 | ||
14-Day RSI | 47.77 | ||
14-Day ATR ($) | 0.282109 | ||
20-Day SMA ($) | 2.63456 | ||
12-1 Month Momentum % | -57.54 | ||
52-Week Range ($) | 1.95 - 7.19 | ||
Shares Outstanding (Mil) | 112.82 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Procaps Group SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Procaps Group SA Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Procaps Group SA Frequently Asked Questions
What is Procaps Group SA(PROC)'s stock price today?
The current price of PROC is $2.60. The 52 week high of PROC is $7.19 and 52 week low is $1.95.
When is next earnings date of Procaps Group SA(PROC)?
The next earnings date of Procaps Group SA(PROC) is 2024-02-14 Est..
Does Procaps Group SA(PROC) pay dividends? If so, how much?
Procaps Group SA(PROC) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |